|Title:||Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B|
|Abstract:||Use of a compound of formula (I) or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of hepatitis B is disclosed. ##STR00001##|
|Inventor(s):||Belleau; Pierrette (Montreal, CA), Nguyen-Ba; Nghe (La Praire, CA), Belleau; Bernard (Westmont, CA)|
|Assignee:||Shire BioChem Inc. (Quebec, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Dosage form;|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|SOLUTION;ORAL||021004||Dec 8, 1998||RX||Yes||RE39155*PED||<disabled>|
|TABLET;ORAL||021003||Dec 8, 1998||RX||Yes||RE39155*PED||<disabled>|
|This preview shows a limited data set|
Subscribe for full access , or try a free trial
Export unavailable in trial.
Subscribe for complete access.
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|United Kingdom||9100039||Jan 03, 1991|
|United Kingdom||9109913||May 07, 1991|
|PCT Filed||January 03, 1992||PCT Application Number:||PCT/CA92/00001|
|PCT Publication Date:||July 23, 1992||PCT Publication Number:||WO92/11852|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.